← Leaderboards
Iannis Aifantis
New York University School Of Medicine
$31,581,069
Attributed
$44,594,749
Total exposure
21
Grants
17
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $3.9M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$44,594,749 · 21
By mechanism
R01$41,029,320 · 16
P01$2,427,044 · 2
R56$422,604 · 1
R21$398,820 · 1
P50$316,961 · 1
Top collaborators
- Ross L Levine20 shared
- Omar Abdel-Wahab5 shared
- Eva Hernando5 shared
- Susan Ruth Schwab5 shared
- Luca Busino4 shared
- Daniel Starczynowski4 shared
- Ann-Kathrin Eisfeld3 shared
- E. Jane Albert Hubbard2 shared
Most similar at New York University School Of Medicine
Same institution · by research overlap
- Charles Lockwood$12,124,373
- Susan Ruth Schwab$12,737,775
- Hyunsoo Chung$54,538
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoMutationCellsLeukemiaGeneticAnimal ModelMolecularMalignant NeoplasmsMediatingGene ExpressionTumorIn VitroOncogenicGenesAffectProteinsMouse ModelTumor Suppressor ProteinsSignal TransductionHematopoietic Stem CellsRegulationBaseMalignant - DescriptorGrowth
Grant awards (101)
Mapping and targeting 3D regulatory elements in leukemia and lymphoma$690,772
R01 · FY2025 · CA · contact PI
Dissecting innate immune signaling in pre-leukemia evolution$638,243
R01 · FY2025 · CA
The role of inflammation in the regulation of immune response in acute myeloid leukemia$573,470
R01 · FY2025 · CA · contact PI
mRNA stability and its impact on hematopoiesis and acute leukemia$540,134
R01 · FY2025 · CA · contact PI
Oncogenic triggers and their influence on 3D chromosomal architecture$432,413
P01 · FY2025 · CA · contact PI
Mapping and targeting 3D regulatory elements in leukemia and lymphoma-Supplement$244,309
R01 · FY2025 · CA · contact PI
Regulation of emergency hematopoiesis by the ubiquitin-proteasome system$615,348
R01 · FY2024 · HL
Dissecting innate immune signaling in pre-leukemia evolution$606,333
R01 · FY2024 · CA
The role of inflammation in the regulation of immune response in acute myeloid leukemia$543,631
R01 · FY2024 · CA · contact PI
Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia$528,062
R01 · FY2024 · CA
mRNA stability and its impact on hematopoiesis and acute leukemia$513,127
R01 · FY2024 · CA · contact PI
Regulation of emergency hematopoiesis by the ubiquitin-proteasome system$627,906
R01 · FY2023 · HL
Dissecting innate immune signaling in pre-leukemia evolution$625,479
R01 · FY2023 · CA
The role of inflammation in the regulation of immune response in acute myeloid leukemia$570,317
R01 · FY2023 · CA · contact PI
Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia$544,739
R01 · FY2023 · CA
mRNA stability and its impact on hematopoiesis and acute leukemia$529,332
R01 · FY2023 · CA · contact PI
Mechanisms of enhancer regulation in leukemia$492,409
R01 · FY2023 · CA · contact PI
Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture$411,831
P01 · FY2023 · CA · contact PI
Dissecting innate immune signaling in pre-leukemia evolution$652,991
R01 · FY2022 · CA
Regulation of emergency hematopoiesis by the ubiquitin-proteasome system$633,818
R01 · FY2022 · HL
Role of TET2 mutations in malignant transformation and acute myeloid leukemia$626,401
R01 · FY2022 · CA
Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia$544,735
R01 · FY2022 · CA
mRNA stability and its impact on hematopoiesis and acute leukemia$540,134
R01 · FY2022 · CA · contact PI
Mechanisms of enhancer regulation in leukemia$492,409
R01 · FY2022 · CA · contact PI
Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture$324,528
P01 · FY2022 · CA · contact PI
Developmental Research Program$78,816
P50 · FY2022 · CA · contact PI
Regulation of emergency hematopoiesis by the ubiquitin-proteasome system$653,245
R01 · FY2021 · HL
Role of TET2 mutations in malignant transformation and acute myeloid leukemia$639,187
R01 · FY2021 · CA
Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia$555,855
R01 · FY2021 · CA
Mechanisms of enhancer regulation in leukemia$502,459
R01 · FY2021 · CA · contact PI
The cohesin complex as a tumor suppressor in myeloid leukemia$488,648
R01 · FY2021 · CA · contact PI
Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture$417,802
P01 · FY2021 · CA · contact PI
Developmental Research Program$78,817
P50 · FY2021 · CA · contact PI
Role of TET2 mutations in malignant transformation and acute myeloid leukemia$639,187
R01 · FY2020 · CA
Targeting an RNA Binding Protein Network in Acute Myeloid Leukemia$575,103
R01 · FY2020 · CA
Mechanisms of enhancer regulation in leukemia$502,459
R01 · FY2020 · CA · contact PI
The cohesin complex as a tumor suppressor in myeloid leukemia$496,859
R01 · FY2020 · CA · contact PI
Post-translational control of cancer cell stress response and metastasis$459,505
R01 · FY2020 · CA · contact PI
Mapping cancer micro-environments for acute leukemia$455,428
R01 · FY2020 · CA · contact PI
Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture$420,235
P01 · FY2020 · CA · contact PI
Developmental Research Program$80,510
P50 · FY2020 · CA · contact PI
Role of TET2 mutations in malignant transformation and acute myeloid leukemia$620,011
R01 · FY2019 · CA
Mechanisms of enhancer regulation in leukemia$519,834
R01 · FY2019 · CA · contact PI
The cohesin complex as a tumor suppressor in myeloid leukemia$489,840
R01 · FY2019 · CA · contact PI
Post-translational control of cancer cell stress response and metastasis$445,719
R01 · FY2019 · CA · contact PI
Long non-coding RNAs in hematopoiesis and blood malignancy$443,806
R01 · FY2019 · CA · contact PI
Mapping cancer micro-environments for acute leukemia$441,979
R01 · FY2019 · CA · contact PI
Project 3: Oncogenic triggers and their influence on 3D chromosomal architecture$420,235
P01 · FY2019 · CA · contact PI
Developmental Research Program$78,818
P50 · FY2019 · CA · contact PI
Role of TET2 mutations in malignant transformation and acute myeloid leukemia$642,416
R01 · FY2018 · CA
The cohesin complex as a tumor suppressor in myeloid leukemia$511,640
R01 · FY2018 · CA · contact PI
Post-translational control of cancer cell stress response and metastasis$459,505
R01 · FY2018 · CA · contact PI
Long non-coding RNAs in hematopoiesis and blood malignancy$457,533
R01 · FY2018 · CA · contact PI
Mapping cancer micro-environments for acute leukemia$455,870
R01 · FY2018 · CA · contact PI
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.$381,375
R01 · FY2018 · CA · contact PI
Genetic Dissection of Acute Myeloid Leukemia.$355,993
R01 · FY2018 · CA · contact PI
Role of TET2 mutations in malignant transformation and acute myeloid leukemia$639,626
R01 · FY2017 · CA
The cohesin complex as a tumor suppressor in myeloid leukemia$536,993
R01 · FY2017 · CA · contact PI
Mapping cancer micro-environments for acute leukemia$462,880
R01 · FY2017 · CA · contact PI
Post-translational control of cancer cell stress response and metastasis$459,505
R01 · FY2017 · CA · contact PI
Long non-coding RNAs in hematopoiesis and blood malignancy$457,533
R01 · FY2017 · CA · contact PI
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.$381,375
R01 · FY2017 · CA · contact PI
Genetic Dissection of Acute Myeloid Leukemia.$355,993
R01 · FY2017 · CA · contact PI
Role of TET2 mutations in malignant transformation and acute myeloid leukemia$639,626
R01 · FY2016 · CA
Mapping cancer micro-environments for acute leukemia$463,557
R01 · FY2016 · CA · contact PI
Long non-coding RNAs in hematopoiesis and blood malignancy$457,533
R01 · FY2016 · CA · contact PI
Post-translational control of cancer cell stress response and metastasis$445,437
R01 · FY2016 · CA · contact PI
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.$381,375
R01 · FY2016 · CA · contact PI
Genetic Dissection of Acute Myeloid Leukemia.$355,993
R01 · FY2016 · CA · contact PI
Role of TET2 mutations in malignant transformation and acute myeloid leukemia$639,626
R01 · FY2015 · CA
Long non-coding RNAs in hematopoiesis and blood malignancy$457,533
R01 · FY2015 · CA · contact PI
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.$381,375
R01 · FY2015 · CA · contact PI
Genetic Dissection of Acute Myeloid Leukemia.$355,993
R01 · FY2015 · CA · contact PI
Mechanisms of T cell leukemia induction and maintenance$340,155
R01 · FY2015 · CA · contact PI
Role of TET2 mutations in malignant transformation and acute myeloid leukemia$620,436
R01 · FY2014 · CA
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia.$381,375
R01 · FY2014 · CA · contact PI
Genetic Dissection of Acute Myeloid Leukemia.$373,368
R01 · FY2014 · CA · contact PI
Mechanisms of T cell leukemia induction and maintenance$341,066
R01 · FY2014 · CA · contact PI
Regulation of hematopoietic stem cell differentiation$290,603
R01 · FY2014 · CA · contact PI
Regulation of hematopoietic stem cell differentiation$140,136
R01 · FY2014 · CA · contact PI
Role of TET2 mutations in malignant transformation and acute myeloid leukemia$626,964
R01 · FY2013 · CA
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia$320,692
R01 · FY2013 · CA · contact PI
Mechanisms of T cell leukemia induction and maintenance$319,746
R01 · FY2013 · CA · contact PI
Regulation of hematopoietic stem cell differentiation$281,616
R01 · FY2013 · CA · contact PI
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia$341,161
R01 · FY2012 · CA · contact PI
Mechanisms of T cell leukemia induction and maintenance$340,155
R01 · FY2012 · CA · contact PI
Regulation of hematopoietic stem cell differentiation$299,591
R01 · FY2012 · CA · contact PI
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia$341,161
R01 · FY2011 · CA · contact PI
Mechanisms of T cell leukemia induction and maintenance$340,155
R01 · FY2011 · CA · contact PI
Regulation of hematopoietic stem cell differentiation$299,591
R01 · FY2011 · CA · contact PI
Modifiers of Notch stability and their role in cancer$178,275
R21 · FY2011 · CA · contact PI
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia$351,713
R01 · FY2010 · CA · contact PI
Mechanisms of T cell leukemia induction and maintenance$350,675
R01 · FY2010 · CA · contact PI
Regulation of hematopoietic stem cell differentiation$308,858
R01 · FY2010 · CA · contact PI
Modifiers of Notch stability and their role in cancer$220,545
R21 · FY2010 · CA · contact PI
The role of the SCF/FBW7 ubiquitin ligase complex in hematopiesis and leukemia$351,713
R01 · FY2009 · CA · contact PI
preTCR as an inducer of cell survival and transformation$317,104
R01 · FY2008 · CA · contact PI
Hedgehog signaling as a novel regulator of hematopoiesis$422,604
R56 · FY2007 · AI · contact PI
preTCR as an inducer of cell survival and transformation$316,480
R01 · FY2007 · CA · contact PI
preTCR as an inducer of cell survival and transformation$294,110
R01 · FY2006 · CA · contact PI
preTCR as an inducer of cell survival and transformation$301,188
R01 · FY2005 · CA